SCM
QNRX

Soleus Capital Management’s Quoin Pharmaceuticals QNRX Stock Holding History

Soleus Capital Management’s Portfolio QNRX Stock Details QNRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Hold
72,730
– – 0.01% 94
2026
Q1 		$480K Buy
72,730
+47,730
+191% +$432K 0.02% 83
2025
Q4 		$361K Buy
+25,000
New +$340K 0.01% 90

Other funds holding QNRX

DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SC
SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

Soleus Capital Management's QNRX Position: Q2 2026 in Review

Soleus Capital Management held its Quoin Pharmaceuticals (QNRX) position steady in Q2 2026 at 72,730 shares worth $352K. The position accounts for 0.01% of the portfolio, ranked #94.

Soleus Capital Management first reported a position in QNRX in Q4 2025 and has held it in 3 quarters since. The position peaked at $480K in Q1 2026. 20 funds tracked by Wall St. Rank hold QNRX as of Q2 2026.

  • Soleus Capital Management held 72,730 shares of Quoin Pharmaceuticals worth $352K as of Q2 2026.
  • Soleus Capital Management left its Quoin Pharmaceuticals share count unchanged in Q2 2026.
  • Quoin Pharmaceuticals made up 0.01% of Soleus Capital Management's portfolio in Q2 2026, its #94 holding.
  • Soleus Capital Management first reported a position in Quoin Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Soleus Capital Management's Quoin Pharmaceuticals position peaked at $480K in Q1 2026.
  • 20 funds tracked by Wall St. Rank held Quoin Pharmaceuticals as of Q2 2026.

Based on Soleus Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.